Patents by Inventor Michelle BOYTIM

Michelle BOYTIM has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • METHODS FOR TREATING FAMILIAL ADENOMATOUS POLYPOSIS
    Publication number: 20220040130
    Abstract: Provided are methods for preventing or delaying the need for surgical intervention in a patient having familial adenomatous polyposis (FAP) and an at least partially intact lower gastrointestinal tract. Also provided are methods for preventing or delaying the formation of neoplasia and/or cancer in a patient having FAP. The methods comprise administering an effective amount of a pharmaceutical therapy that comprises eflornithine and sulindac to a patient having FAP and an intact lower gastrointestinal tract.
    Type: Application
    Filed: March 15, 2021
    Publication date: February 10, 2022
    Inventors: Eugene Gerner, Alfred Cohen, Michelle Boytim
  • Methods for treating familial adenomatous polyposis
    Patent number: 10945981
    Abstract: Provided are methods for preventing or delaying the need for surgical intervention in a patient having familial adenomatous polyposis (FAP) and an at least partially intact lower gastrointestinal tract. Also provided are methods for preventing or delaying the formation of neoplasia and/or cancer in a patient having FAP. The methods comprise administering an effective amount of a pharmaceutical therapy that comprises eflornithine and sulindac to a patient having FAP and an intact lower gastrointestinal tract.
    Type: Grant
    Filed: May 15, 2020
    Date of Patent: March 16, 2021
    Assignee: Cancer Prevention Pharmaceuticals, Inc.
    Inventors: Eugene Gerner, Alfred Cohen, Michelle Boytim
  • METHODS FOR TREATING FAMILIAL ADENOMATOUS POLYPOSIS
    Publication number: 20200360329
    Abstract: Provided are methods for preventing or delaying the need for surgical intervention in a patient having familial adenomatous polyposis (FAP) and an at least partially intact lower gastrointestinal tract. Also provided are methods for preventing or delaying the formation of neoplasia and/or cancer in a patient having FAP. The methods comprise administering an effective amount of a pharmaceutical therapy that comprises eflornithine and sulindac to a patient having FAP and an intact lower gastrointestinal tract.
    Type: Application
    Filed: May 15, 2020
    Publication date: November 19, 2020
    Inventors: Eugene GERNER, Alfred COHEN, Michelle BOYTIM